HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options
By SquaredTown on May 31, 2025
The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer drug in patients with breast or lung cancer and active brain metastases, and leptomeningeal disease from solid tumors. These results were presented as an oral...